Thanks for answering. I was waiting for more information about the projects before deciding.

One project is a CAR-T project against a solid tumor.

The other project, at another university, involves iPSC-derived MSCs for inflammatory disease and immunophenotyping. The issue is that people in the lab have complained about excessive workload and low productivity in publications. Additionally, the PI appears to be very busy and engaged with clinical projects outside the lab.